http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113069556-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6953 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69 |
| filingDate | 2021-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113069556-B |
| titleOfInvention | Oxidized alginic acid fiber membrane of cladinostat and preparation method thereof |
| abstract | The invention relates to the technical field of medical materials, and relates to an oxidized alginic acid fiber membrane of a branchlet natamycin and a preparation method thereof, wherein the preparation method comprises the following specific steps: preparing oxidized alginate fibers: sodium periodate is used to react with alginic acid fiber to obtain oxidized alginic acid fiber; soaking oxidized alginate fiber in glycerol water solution, rinsing, drying, and storing in a dry sterile centrifuge tube; soaking oxidized alginate fiber in natamycin water solution, oscillating and incubating at 50 deg.C in dark for 36 hr, washing with ethanol water solution and deionized water twice, and oven drying; the natamycin is grafted on the surface of the oxidized alginic acid fiber membrane, so that the eye irritation and discomfort of the natamycin can be reduced, the half-life period of the medicine can be prolonged, the utilization rate of the medicine can be improved, and the treatment effect of the fungal keratitis can be improved; the preparation process is simple, the cost is low, the product is easy to store, and the market prospect is wide. |
| priorityDate | 2021-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.